CAH
44
7
WAT
55
11
PFE
37
4
INTC
35
4
TAP
57
6
D
32
10
GOOGL
62
6
PX
56
3
NWS
69
5
DIS
70
2
LUV
45
3
V
70
14
XYL
29
4
CLX
65
2
WHR
61
3
AAP
26
5
ACN
54
2
PFG
27
7
INTU
54
2
CF
47
5
CAH
44
7
WAT
55
11
PFE
37
4
INTC
35
4
TAP
57
6
D
32
10
GOOGL
62
6
PX
56
3
NWS
69
5
DIS
70
2
LUV
45
3
V
70
14
XYL
29
4
CLX
65
2
WHR
61
3
AAP
26
5
ACN
54
2
PFG
27
7
INTU
54
2
CF
47
5
Financhill
Back

Bio-Rad Laboratories 10K Form

Sell
44

BIO
Bio-Rad Laboratories

Last Price:
$327.54
Seasonality Move:
8.52%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BIO News And Ratings

See the #1 stock for the next 7 days that we like better than BIO

BIO Financial Statistics

Sales & Book Value

Annual Sales: $2.7B
Cash Flow: $100M
Price / Cash Flow: 41.6
Annual Sales: $267.46
Price / Book: 1.22

Profitability

EPS (TTM): -27.33000
Net Income (TTM): $-778.7M
Gross Margin: $1.4B
Return on Equity: -9.62%
Return on Assets: -6.82%

Bio-Rad Laboratories Earnings Forecast

Key Bio-Rad Laboratories Financial Ratios

  • The Gross Profit Margin over the past 40 years for BIO is 53.42%.
  • The Selling, General & Administrative Expenses for BIO have been equal to 31.51% of Gross Profit Margin.
  • The Research & Development expenses have been 9.26% of Revenue.
  • The Interest Expense is -7.76% of Operating Income.
  • The Net Earning history of BIO is -23.86% of Total Revenues.
  • Per Share Earnings over the last 40 years have been positive in 26 years.

Bio-Rad Laboratories Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: BIO
CUSIP: 090572
Website: bio-rad.com

Debt

Debt-to-Equity Ratio: 0.16
Current Ratio: 6.14
Quick Ratio: 4.19

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 28.89

BIO Technical Analysis vs Fundamental Analysis

Sell
44
Bio-Rad Laboratories (BIO) is a Sell

Is Bio-Rad Laboratories a Buy or a Sell?